APRIL 15, 2011 -- PART 1: ACHIEVEMENTS OF THE PAST YEAR
The second Sage Bionetworks Commons Congress will be held in San Francisco on April 15-16, 2011. The theme will be the move towards personalized, patient-driven medicine, and the role that Sage Bionetworks can play in that transition. Expect reports from the Sage Federation, Working Groups, and exciting projects like SageCite, poster sessions and evening activities.
A patient perspective on healthcare followed by summaries of the new projects that have emerged since the 2010 Congress as a demonstration that the efforts of the Commons over the past year have paid off. The Federation, the Commons Platform, Repository and independent projects like SageCite will be featured. Sage Bionetworks will review its own internal development work and a new journal for sharing models will be announced.
Dr. Schadt oversees the scientific strategy for Pacific Biosciences, including creating the vision for next-generation applications of the company's technology, contributing to the evolution of Pacific Biosciences' transformative sequencing technology, and playing a key role in the company's strategic relationships.
He is also a founding member of Sage Bionetworks - an open access genomics initiative designed to build and support databases and an accessible platform for creating innovative dynamic disease models.
The practice concerned with the maintenance of health and the prevention, diagnosis, and treatment of disease. Medicine may be practiced in doctors' offices, health maintenance organization facilities, hospitals, and clinics. In addition to family practice, internal medicine, and specialties for specific body systems, it includes research, public health, epidemiology, and pharmacology. Each country sets its own requirements for medical degrees (M.D.'s) and licenses. Medical boards and councils set standards and oversee medical education. Boards of certification have stringent requirements for physicians seeking to practice a specialty, and they stress continuing education. Advances in therapy (seetherapeutics) and diagnosis have raised complex legal and moral issues in areas such as abortion, euthanasia, and patients' rights. Recent changes include treating patients as partners in their own care and taking cultural factors into consideration.